Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

197.44
Delayed Data
As of Jul 31
 -1.85 / -0.93%
Today’s Change
150.06
Today|||52-Week Range
208.88
+6.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues549.0M584.5M600.3M636.2M
 
 
 
 
 
Cost of Goods Sold51.9M49.4M69.4M52.0M
 
 
 
 
 
Depreciation And Amortization9.4M18.5M10.6M--
 
 
 
 
 
Operating ExpensesGross Income487.8M516.5M520.4M584.2M
 
 
 
 
 
General Expenses249.0M294.3M397.6M353.1M
 
 
 
 
 
Research And Development97.3M124.9M216.5M131.7M
 
 
 
 
 
Total Operating Expenses310.2M362.3M477.6M405.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income238.8M222.1M122.7M231.1M
 
 
 
 
 
Extraordinary Credit12.5M13.9M7.7M--
 
 
 
 
Extraordinary Charge-8.3M-33.5M-19.0M-50.0M
 
 
 
 
 
Interest Expense On Debt655.0K549.0K651.0K--
 
 
 
 
Other Expenses-8.4M1.2M-6.6M-3.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income236.2M205.3M106.9M177.3M
 
 
 
 
 
Income Taxes-58.5M-52.0M-15.6M-7.1M
 
 
 
 
 
Net Income177.7M153.3M91.3M170.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS198.1M198.7M199.4M202.2M
 
 
 
 
 
Shares To Calculate EPS Diluted201.3M201.7M202.0M204.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.88$0.76$0.45$0.83
 
 
 
 
 
EPS Diluted$0.88$0.76$0.45$0.83